China National Medicines Corporation Ltd. (SHA:600511)

SHA:600511 Revenue

China National Medicines Corporation had revenue of 13.88B CNY in the quarter ending September 30, 2026, with 0.95% growth. This brings the company's total for the last twelve months to 53.69B, up 3.36% year-over-year. In the year 2025, China National Medicines Corporation had annual revenue of 52.47B with 3.70% growth. That makes China National Medicines Corporation the 1,774th largest company in the world by revenue and 186th in China.

• Revenue (ttm): 53.69B
• Revenue Growth: +3.36%
• P/S Ratio: 0.39
• Revenue / Employee: 17.76M
• Employees: 3,024
• Market Cap: 20.63B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Commercial Segment 51.69B 97.9%
• Others 1.13B 2.1%

Fiscal year ended Dec 31, 2025 See the full SHA:600511 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.47B	1.87B	3.70%
Dec 31, 2024	50.60B	901.40M	1.81%
Dec 31, 2023	49.70B	4.20B	9.23%
Dec 31, 2022	45.50B	-970.02M	-2.09%
Dec 31, 2021	46.47B	6.09B	15.08%

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error